These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 3631972)
1. [The synergistic effect of human recombinant TNF in combination with various anti-cancer drugs]. Yamauchi N; Watanabe N; Ohtsuka Y; Sone H; Neda H; Maeda M; Niitsu Y; Urushizaki I Gan To Kagaku Ryoho; 1987 Sep; 14(9):2730-4. PubMed ID: 3631972 [TBL] [Abstract][Full Text] [Related]
2. Synergistic cytotoxicity of recombinant human TNF and various anti-cancer drugs. Watanabe N; Niitsu Y; Yamauchi N; Ohtsuka Y; Sone H; Neda H; Maeda M; Urushizaki I Immunopharmacol Immunotoxicol; 1988; 10(1):117-27. PubMed ID: 2452179 [TBL] [Abstract][Full Text] [Related]
3. [Combined effect of PT-050 (recombinant human TNF) and antitumor drugs on syngeneic murine tumors]. Nakata K; Yoshida H; Kashimoto S; Sohmura Y; Nakamura S; Taguchi T Gan To Kagaku Ryoho; 1986 Oct; 13(11):3186-93. PubMed ID: 3096217 [TBL] [Abstract][Full Text] [Related]
4. [Anti-tumor effect of human recombinant TNF]. Watanabe N; Niitsu Y; Neda H; Yamauchi N; Maeda M; Kuriyama H; Sone H Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):780-7. PubMed ID: 3291772 [TBL] [Abstract][Full Text] [Related]
5. [Synergistic effects of human recombinant TNF and hyperthermia on in vitro cytotoxicity and artificial metastases]. Umeno H; Watanabe N; Sone H; Neda H; Yamauchi N; Maeda M; Niitsu Y; Urushizaki I Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1286-91. PubMed ID: 3579327 [TBL] [Abstract][Full Text] [Related]
6. [Potentiation of the cytotoxic effects of anticancer drugs on human genitourinary neoplastic cells by recombinant gamma-interferon]. Yamamoto S; Tanaka H; Namba M Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):699-705. PubMed ID: 3103539 [TBL] [Abstract][Full Text] [Related]
7. [Chemotherapy of carcinoma of the prostate and testis: experimental study in vivo and in vitro]. Okada K; Kanamaru H; Yoshiki T; Hashimura T; Nishimura K; Hida S; Nishio Y; Oishi K; Yoshida O; Yamauchi T Hinyokika Kiyo; 1988 Nov; 34(11):1911-6. PubMed ID: 2468265 [TBL] [Abstract][Full Text] [Related]
8. [Chemotherapy of ovarian cancer based on in vitro (HTCA) and in vivo (nude mice) chemosensitivity testing]. Sagawa T; Yamashita K; Kawamura M; Shimizu T; Haga H; Yorozu Y; Kasamo M; Fujita M Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1197-204. PubMed ID: 2411831 [TBL] [Abstract][Full Text] [Related]
9. [Potentiation of chemotherapeutic activity by a Chinese herb medicine juzen-taiho-toh]. Komiyama K; Hirokawa Y; Zhibo Y; Umezawa I; Hata T Gan To Kagaku Ryoho; 1988 May; 15(5):1715-9. PubMed ID: 3130806 [TBL] [Abstract][Full Text] [Related]
10. TNF-alpha augments intratumoural concentrations of doxorubicin in TNF-alpha-based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effects. van der Veen AH; de Wilt JH; Eggermont AM; van Tiel ST; Seynhaeve AL; ten Hagen TL Br J Cancer; 2000 Feb; 82(4):973-80. PubMed ID: 10732774 [TBL] [Abstract][Full Text] [Related]
11. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II). Mizutani Y; Yoshida O; Bonavida B J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929 [TBL] [Abstract][Full Text] [Related]
12. Relationship between modulation of natural killer cell activity and antitumor activity of bropirimine when used in combination with various types of chemotherapeutic drugs. Li LH; DeKoning TF; Wallace TL Cancer Res; 1987 Nov; 47(22):5894-900. PubMed ID: 3664490 [TBL] [Abstract][Full Text] [Related]
13. Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin. Mizutani Y; Nakao M; Ogawa O; Yoshida O; Bonavida B; Miki T J Urol; 2001 Jan; 165(1):263-70. PubMed ID: 11125422 [TBL] [Abstract][Full Text] [Related]
14. Potentiation by squalene of the cytotoxicity of anticancer agents against cultured mammalian cells and murine tumor. Nakagawa M; Yamaguchi T; Fukawa H; Ogata J; Komiyama S; Akiyama S; Kuwano M Jpn J Cancer Res; 1985 Apr; 76(4):315-20. PubMed ID: 2408954 [TBL] [Abstract][Full Text] [Related]
15. Combination antitumor therapy with rabbit tumor necrosis factor and chemo- and immuno-therapeutic agents against murine tumors. Gatanaga T; Takahashi K; Yamazaki M; Mizuno D; Abe S Jpn J Cancer Res; 1985 Jul; 76(7):631-6. PubMed ID: 3928560 [TBL] [Abstract][Full Text] [Related]
16. Synergistic antitumor activity of TRAIL combined with chemotherapeutic agents in A549 cell lines in vitro and in vivo. Fan QL; Zou WY; Song LH; Wei W Cancer Chemother Pharmacol; 2005 Feb; 55(2):189-96. PubMed ID: 15290100 [TBL] [Abstract][Full Text] [Related]
17. [Combination therapy of CPT-11, a camptothecin derivative, with various antitumor drugs against L 1210 leukemia]. Furuta T; Yokokura T Gan To Kagaku Ryoho; 1991 Mar; 18(3):393-402. PubMed ID: 1900684 [TBL] [Abstract][Full Text] [Related]
18. Cures and partial regression of murine and human tumors by recombinant human tumor necrosis factor. Creasey AA; Reynolds MT; Laird W Cancer Res; 1986 Nov; 46(11):5687-90. PubMed ID: 3756916 [TBL] [Abstract][Full Text] [Related]
19. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo. Singh TR; Shankar S; Chen X; Asim M; Srivastava RK Cancer Res; 2003 Sep; 63(17):5390-400. PubMed ID: 14500373 [TBL] [Abstract][Full Text] [Related]